Strata Skin Sciences – Consensus Indicates Potential 166.7% Upside

Broker Ratings

Strata Skin Sciences found using ticker (SSKN) have now 3 analysts covering the stock with the consensus suggesting a rating of ‘Strong_Buy’. The target price ranges between 5 and 3 calculating the mean target price we have 3.92. Given that the stocks previous close was at 1.47 this is indicating there is a potential upside of 166.7%. The 50 day moving average now sits at 1.51 while the 200 day moving average is 1.39. The market capitalisation for the company is $47m. Visit the company website at: http://www.strataskinsciences.com

STRATA Skin Sciences, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States and Asia. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC excimer laser and VTRAC lamp systems that are used for the treatment of skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. The company distributes its products internationally through distributors, and domestically directly to physicians. STRATA Skin Sciences was founded in 1989 and is based in Horsham, Pennsylvania.

Share on Stocktwits

Good news travels fast (but only if you make that happen):

Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on facebook
Facebook
Share on email
Email
Share on whatsapp
WhatsApp